327 related articles for article (PubMed ID: 28334702)
1. In vitro Antibacterial Activity of 7-Substituted-6-Fluoroquinolone and 7-Substituted-6,8-Difluoroquinolone Derivatives.
Leyva-Ramos S; de Loera D; Cardoso-Ortiz J
Chemotherapy; 2017; 62(3):194-198. PubMed ID: 28334702
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones.
Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A
Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
[TBL] [Abstract][Full Text] [Related]
5. N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.
Asadipour A; Moshafi MH; Khosravani L; Moghimi S; Amou E; Firoozpour L; Ilbeigi G; Beiki K; Soleimani E; Foroumadi A
Daru; 2018 Dec; 26(2):199-207. PubMed ID: 30392156
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and in vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(alkoxyimino)-2-(aminomethyl)azetidine moiety.
Lv K; Sun Y; Sun L; Wei Z; Guo H; Wu J; Liu M
ChemMedChem; 2012 Jul; 7(7):1230-6. PubMed ID: 22639240
[TBL] [Abstract][Full Text] [Related]
7. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens.
Kazamori D; Aoi H; Sugimoto K; Ueshima T; Amano H; Itoh K; Kuramoto Y; Yazaki A
Int J Antimicrob Agents; 2014 Nov; 44(5):443-9. PubMed ID: 25239276
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.
Butler MM; Lamarr WA; Foster KA; Barnes MH; Skow DJ; Lyden PT; Kustigian LM; Zhi C; Brown NC; Wright GE; Bowlin TL
Antimicrob Agents Chemother; 2007 Jan; 51(1):119-27. PubMed ID: 17074800
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-methyl-3-methylaminopiperidin-1-yl)quinolones.
Wan ZL; Chai Y; Liu ML; Guo HY; Sun LY
Yao Xue Xue Bao; 2010 Jul; 45(7):860-8. PubMed ID: 20931783
[TBL] [Abstract][Full Text] [Related]
12. Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.
Nguyen ST; Ding X; Butler MM; Tashjian TF; Peet NP; Bowlin TL
Bioorg Med Chem Lett; 2011 Oct; 21(19):5961-3. PubMed ID: 21865042
[TBL] [Abstract][Full Text] [Related]
13. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.
Li GQ; Yuan M; Yang XY; Li CR; Hu XX; Zhang WX; Lou RH; Guo HY; You XW; Cen S; Jiang JD; You XF
Chemotherapy; 2012; 58(3):175-84. PubMed ID: 22699239
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of N-[5-(chlorobenzylthio)-1,3,4-thiadiazol-2-yl] piperazinyl quinolone derivatives.
Foroumadi A; Firoozpour L; Emami S; Mansouri S; Ebrahimabadi AH; Asadipour A; Amini M; Saeid-Adeli N; Shafiee A
Arch Pharm Res; 2007 Feb; 30(2):138-45. PubMed ID: 17366732
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antimicrobial evaluation of novel glycosylated-fluoroquinolones derivatives.
Mohammed AAM; Suaifan GARY; Shehadeh MB; Okechukwu PN
Eur J Med Chem; 2020 Sep; 202():112513. PubMed ID: 32623216
[TBL] [Abstract][Full Text] [Related]
17. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.
Kocsis B; Domokos J; Szabo D
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):34. PubMed ID: 27215369
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Molecular Docking of 1-Cyclopropyl-6- Fluoro-4-Oxo-7-{4-[2-(4-Substituted-Phenyl)-2-(Substituted)-Ethyl] -1-Piperazinyl}-1,4-Dihydroquinoline-3-Carboxylic Acid as an Antimicrobial Agents.
Patel MM; Patel LJ
Curr Drug Discov Technol; 2017; 14(4):255-269. PubMed ID: 28240185
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents.
Fedorowicz J; Sączewski J; Konopacka A; Waleron K; Lejnowski D; Ciura K; Tomašič T; Skok Ž; Savijoki K; Morawska M; Gilbert-Girard S; Fallarero A
Eur J Med Chem; 2019 Oct; 179():576-590. PubMed ID: 31279292
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives.
Chai Y; Liu ML; Lv K; Feng LS; Li SJ; Sun LY; Wang S; Guo HY
Eur J Med Chem; 2011 Sep; 46(9):4267-73. PubMed ID: 21764484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
